Artificial insemination has been a landmark procedure in improving animal agriculture over the past 150 years. The utility of artificial insemination has facilitated a rapid improvement in animal genetics across agricultural species, leading to improvements of growth, health and productivity in poultry, swine, equine and cattle species. The utility of artificial insemination, as with all assisted reproductive technologies side-steps thousands of years of evolution that has led to the development of physiological systems to ensure the transmission of genetics from generation to generation. The perceived manipulation of these physiological systems as a consequence of assisted reproduction are points of interest in which research could potentially improve the success of these technologies. Indeed, seminal fluid is either removed or substantially diluted when semen is prepared for artificial insemination in domestic species. Although seminal fluid is not a requirement for pregnancy, could the removal of seminal fluid from the ejaculate have negative consequences on reproductive outcomes that could be improved to further the economic benefit of artificial insemination? One such potential influence of seminal fluid on reproduction stems from the question; how does the allogeneic foetus survive gestation in the face of the maternal immune system? Observation of the maternal immune system during pregnancy has noted maternal immune tolerance to paternal-specific antigens; a mechanism by which the maternal immune system tolerates specific paternal antigens expressed on the foetus. In species like human or rodent, implantation occurs days after fertilisation and as such the mechanisms to establish antigen-specific tolerance must be initiated very early during pregnancy. We and others propose that these mechanisms are initiated at the time of insemination when paternal antigens are first introduced to the maternal immune system. It is unclear whether such mechanisms would also be involved in domestic species, such as cattle, where implantation occurs weeks later in gestation. A new paradigm detailing the importance of paternal–maternal communication at the time of insemination is becoming evident as it relates to maternal tolerance to foetal antigen and ultimately pregnancy success.

The significance of contact with microbes in early life for subsequent health has been the subject of intense research during the last 2 decades. Disturbances in the establishment of the indigenous intestinal microbiome caused by cesarean section delivery or antibiotic exposure in early life have been linked to the risk of immune-mediated and inflammatory conditions such as atopic disorders, inflammatory bowel disease and obesity later in life. Distinct microbial populations have recently been discovered at maternal sites including the amniotic cavity and breast milk, as well as meconium, which have previously been thought to be sterile. Our understanding of the impact of fetal microbial contact on health outcomes is still rudimentary. Breast milk is known to modulate immune and metabolic programming. The breast milk microbiome is hypothesized to guide infant gut colonization and is affected by maternal health status and mode of delivery. Immunomodulatory factors in breast milk interact with the maternal and infant gut microbiome and may mediate some of the health benefits associated with breastfeeding. The intimate connection between the mother and the fetus or the infant is a potential target for microbial therapeutic interventions aiming to support healthy microbial contact and protect against disease.